Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2012
10/31/2012EP2515855A2 Combination therapy for COPD
10/31/2012EP2515854A2 Aerosol formulation for copd
10/31/2012EP2515853A2 Combination therapy for COPD
10/31/2012EP2515848A1 Dry powder combination of tiotropium, a corticosteroid and a cromoglicic acid derivative
10/31/2012CN102762204A Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection
10/31/2012CN102757950A Expression and purification of super-bacteria New-Delhi-Metallo-dependent beta-lactamase NDM-1, and crystal structure of beta-lactamase NDM-1
10/31/2012CN102755868A Microcapsules produced from blended sol-gel precursors and method for producing the same
10/31/2012CN102755649A Pharmaceutical composition and related methods
10/31/2012CN102755648A Preparation method of anti-aging human universal nutritional supplement
10/31/2012CN102755646A Medicament for treating TNF alpha related disorder
10/31/2012CN102755645A Influenza vaccines with reduced amount of emulsion adjuvant
10/31/2012CN102755374A Acceleration agent of calcium absorption
10/31/2012CN102755321A Combinations comprising antimuscarinic agents and PDE4 inhibitors
10/31/2012CN102755312A Application of compound with flavone skeleton structure as Parkinsonism treating medicine
10/31/2012CN102755309A Application of cajanin to preparation of medicament for treating or preventing caput femoris necrosis
10/31/2012CN102151242B In-situ gel slow-release preparation for anti-tuberculosis drugs and preparation method thereof
10/31/2012CN101972478B 抗体治疗 Antibody therapy
10/30/2012US8299094 Hepatitis C virus inhibitors
10/30/2012US8298570 Sustained release intraocular implants and related methods
10/30/2012US8298563 Polymer no donor predrug nanofiber coating for medical devices and therapy
10/30/2012US8298542 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
10/30/2012US8298540 Methods of modulating T cell-mediated immune responses with anti-P-selectin glycoprotein ligand 1 antibodies
10/30/2012US8298525 Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist
10/30/2012US8298522 Methods of modulating MUC1 expression to inhibit inflammation
10/30/2012US8298521 Treatment for eye disorder
10/30/2012CA2684402C Methods and compositions for treatment of disorders associated with chlamydial and similar bacterial infection
10/30/2012CA2513280C Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition plasma kallikrein
10/30/2012CA2512639C Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/30/2012CA2506244C Methods for inhibiting viral replication in vivo
10/30/2012CA2498731C .beta.-l-2'-deoxynucleosides for the treatment of resistant hbv strains and combination therapies
10/30/2012CA2477101C Use of folates for preventing and treating inflammation and diseases associated with inflammation
10/30/2012CA2474874C Anticholinergic agents, method for producing the same and use thereof as medicaments
10/30/2012CA2467580C Use of lipoxin analogs to promote cell defense against gram-negative infections
10/30/2012CA2456732C Oral pharmaceutical composition containing a combination of ppar.alpha. and a hmg-coa reductase inhibitor
10/30/2012CA2360106C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/26/2012WO2012145684A1 Transient hypoxia inducers and their use
10/26/2012WO2012145098A1 Use of adenosine a3 receptor agonists for treatment of neuropathic pain
10/26/2012WO2012144964A1 Thiocolchicoside, diclofenac and lansoprazole combinations
10/26/2012WO2012144376A1 Therapeutic or prophylactic agent for osteoarthritis
10/26/2012WO2012143787A1 Composition comprising probiotic bacteria capable of restoring the barrier effect of the stomach which is lost during pharmacological treatment of gastric hyperacidity
10/26/2012WO2012143362A1 Infant formula for use in the prevention of cardiovascular diseases
10/26/2012WO2012018948A3 Combination therapy for the treatment of prostate carcinoma
10/26/2012CA2831164A1 Infant formula for use in the prevention of cardiovascular diseases
10/25/2012US20120270948 Polymorphisims in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/25/2012US20120270924 Oligomeric Compounds For The Modultion of HIF-1A Expression
10/25/2012US20120270809 Human transmembrane proteins
10/25/2012US20120270202 Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity
10/25/2012US20120269901 Methods and Compounds Useful to Induce Apoptosis in Cancer Cells
10/25/2012US20120269894 Ophthalmic Depot Formulations for Periocular or Suconjunctival Administration
10/25/2012US20120269878 Composition For Transdermal Delivery Of Fentanyl
10/25/2012US20120269858 Polypeptides
10/24/2012EP2514483A1 Adjuvant immunotherapy for the preventive, curative or palliative treatment of chronic systemic diseases such as cancer, of clinical manifestations associated with these diseases, such as cachexia, and remedying adverse effects of drugs and treatments, such as immunodepression, neutropenia and lymphocytopenia, comprising the association or combination of a specially selected biological response modifier and other antineoplastic compounds and/or other treatments
10/24/2012EP2514473A1 Nitric oxide delivery device
10/24/2012EP2514445A2 Bioactive hydrogel compositions
10/24/2012EP2514440A1 Transdermal preparation containing basic anti-inflammatory agent
10/24/2012EP2514416A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514414A1 Transdermally absorbed preparation of anti-dementia drug
10/24/2012EP2514409A1 Topical pharmaceutical compositions of nimesulide and methylsulfonylmethane
10/24/2012EP2513343A1 Methods and compositions for treating inflammation of skin
10/24/2012EP2512514A1 Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis
10/24/2012EP2512504A1 Treatment composition and method
10/24/2012EP2512485A1 New steroid inhibitors of pgp for use for inhibiting multidrug resistance
10/24/2012EP2512479A1 Methods and compositions for treating peripheral vascular disease
10/24/2012EP2512476A1 Method for treating haematological cancers
10/24/2012EP2512472A1 Therapeutic combinations of theobromine and an antihistamine
10/24/2012EP2512461A1 Chalcones as enhancer of antimicrobial agents
10/24/2012EP2512240A1 Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
10/24/2012EP2512230A1 Non-irritating ophthalmic povidone-iodine compositions
10/24/2012CN102753168A Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
10/24/2012CN102753167A New benzathine salts of ace inhibitors, process for their preparation and their use for the treatment of cardiovascular diseases
10/24/2012CN102753161A Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
10/24/2012CN102753159A Pharmaceutical composition comprising propofol
10/24/2012CN102753158A Transdermally absorbed preparation of anti-dementia drug
10/24/2012CN102750459A Anti-HPV (human papillomavirus) medicine virtual screening method by using DNA helicase E1 of HPV as target point
10/24/2012CN102746414A Sedimentation method of lipopolysaccharides
10/24/2012CN102743762A Receptor-mediated quantum dot tracing targeted drug delivery system, preparation method thereof and application
10/24/2012CN102743757A Medicament for treating overactive bladder caused by bladder outlet obstruction
10/24/2012CN102743756A Compound preparation of propiverine hydrochloride and alpha-receptor antagonist
10/24/2012CN102743755A Composition and method for preventing recurrence of stroke
10/24/2012CN102743754A Esophagus gastrointestinal mucosa protective adhesive preparation and its application
10/24/2012CN102743385A Modulators of atp-binding cassette-transporters
10/24/2012CN102743380A Compounds, formulations, and methods for treating or preventing rosacea
10/24/2012CN102743355A Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic
10/24/2012CN102743340A Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate
10/24/2012CN102743329A Novel intrauterine sustained control release drug delivery system and preparation method thereof
10/24/2012CN101511388B Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders
10/23/2012US8293723 Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications
10/23/2012US8293716 Method of treating cancer by modulation of mortalin
10/23/2012US8293700 Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
10/23/2012CA2523178C Materials and methods to potentiate cancer treatment
10/23/2012CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3
10/23/2012CA2366216C Polycationic carbohydrates as immunostimulants in vaccines
10/18/2012WO2012141773A1 Methods and compositions for reducing shiga toxin induced toxicity in mammals
10/18/2012WO2012140365A1 Use of calixarenes associated with an antibiotic in the treatment of bacterial infections
10/18/2012WO2012140364A1 Use of calixarenes in the treatment of bacterial infections
10/18/2012WO2012139918A1 Methods for treating bacterial infection
10/18/2012WO2012139876A1 Enteric formulations of metabotropic glutamate receptor modulators
10/18/2012US20120264722 Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
10/18/2012US20120264625 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
1 ... 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 ... 1151